News in the Life Sciences Industry

Analysis shows the earlier identification and rule-out of patients without acute myocardial infarction are the key enablers of positive economic outcome

RHEINBREITBACH, Germany, October 8, 2018 /PRNewswire/ --

HENNIGSDORF, Germany, Oct. 8, 2018 /PRNewswire/ -- German diagnostics company sphingotec GmbH has closed a EUR20m growth equity financing round led by international healthcare specialist investors HBM and Wellington Partners.

MONTREAL, October 5, 2018 /PRNewswire/ --

STUTTGART, Germany, Oct. 5, 2018 /PRNewswire/ -- CRB, a leading provider of design and consulting solutions for the global life science marketplace, has announced the opening of a new office in Stuttgart, Germany. The office supports the growing need for experts in project execution to support... Read more ››

BERLIN, Oct. 5, 2018 /PRNewswire/ -- The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have jointly produced and presented today at the EASD's Annual Meeting in Berlin a new guidance document Management of Hyperglycemia in Type 2 Diabetes,... Read more ››

STARNBERG, Germany, Oct. 3, 2018 /PRNewswire/ -- PARI Pharma GmbH, a company focused on the development and commercialization of advanced aerosol delivery systems based on eFlow Technology, announces approval of its optimized eFlow technology nebulizer LAMIRA(TM) together with Insmed's ARIKAYCE(®)... Read more ››

BOULDER, Colo., Oct. 3, 2018 /PRNewswire/ -- ArcherDX, a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine and Merck KGaA, Darmstadt, Germany, the vibrant science and technology company which operates its... Read more ››

MUNICH, Oct. 3, 2018 /PRNewswire/ -- Definiens, the Tissue Phenomics(®) company, has announced the first-ever Definiens Insights Forum to be held at their headquarters in Munich, Germany on October 17, 2018. While space is limited, Read more ››

BERLIN, October 2, 2018 /PRNewswire/ --

BERLIN, Oct. 2, 2018 /PRNewswire/ --

BERLIN, Oct. 2, 2018 /PRNewswire/ -- According to results of a post-hoc analysis people with both type 1 and type 2 diabetes in clinical practice may achieve improved glycaemic control (HbA(1c)) with Tresiba(®) (insulin degludec) versus insulin glargine U100, without an increase in hypoglycaemia... Read more ››

BERLIN, October 2, 2018 /PRNewswire/ --